Lianyungang, China

Duzheng Wang


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):

Title: Duzheng Wang: Innovator in Pharmaceutical Chemistry

Introduction

Duzheng Wang is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of methods for synthesizing important pharmaceutical intermediates. His work has implications for the production of vital medications.

Latest Patents

Duzheng Wang holds a patent for a "Method for preparing dabigatran etexilate intermediate, and intermediate compound." This patent discloses a method for preparing a dabigatran etexilate intermediate, which involves reacting a specific compound with a C-Calkyl alcohol solution of methylamine in an organic solvent. The method is characterized by its simplicity, ease of operation, high yield, and suitability for industrial production. This innovation is crucial for enhancing the efficiency of pharmaceutical manufacturing processes.

Career Highlights

Throughout his career, Duzheng Wang has worked with prominent organizations in the pharmaceutical industry. He has been associated with the Shanghai Institute of Pharmaceutical Industry and the China State Institute of Pharmaceutical Industry. His experience in these institutions has allowed him to refine his skills and contribute to significant advancements in drug development.

Collaborations

Duzheng Wang has collaborated with several professionals in his field, including Yajun Guo and Hanbin Shan. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical methods.

Conclusion

Duzheng Wang's contributions to pharmaceutical chemistry, particularly through his patent on dabigatran etexilate intermediates, highlight his role as an innovator in the industry. His work not only advances scientific knowledge but also enhances the efficiency of drug production processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…